×
×
Our Team
XenImmune is led by a world-class team of experts in immuno-oncology and biotechnology based in the Cambridge, MA.
XenImmune is a pioneering immuno-oncology company applying the powerful and proven biology of organ transplant hyperacute rejection to fight cancer.
XenImmune is a pioneering immuno-oncology company applying the powerful biology of organ transplant hyperacute rejection to fight cancer. Our first-in-class molecules are capable of initiating de novo anti-tumor immune responses through selective "painting" of tumor with foreign blood groups. Our lead therapy has demonstrated proof of concept in common tumor types in both in vitro and in vivo settings.
